ArticleJournal of comparative effectiveness research2025

Comparison of real-world healthcare resource utilization and costs among patients with hereditary angioedema on lanadelumab or berotralstat long-term prophylaxis.

Nicole Princic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.